TY - JOUR
T1 - Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer
AU - Thorenoor, Nithyananda
AU - Faltejskova-Vychytilova, Petra
AU - Hombach, Sonja
AU - Mlcochova, Jitka
AU - Kretz, Markus
AU - Svoboda, Marek
AU - Slaby, Ondrej
N1 - Funding Information:
The work has been supported by the project 'Employment of Best Young Scientists for International Cooperation Empowerment' (CZ.1.07/2.3.00/30.0037), co-financed from the European Social Fund and the state budget of the Czech Republic, by the project "CEITEC" (CZ.1.05./1.1.00/02.0068), MZ CR-RVO (MOU, 00209805), project BBMRI CZ (LM2010004), projects IGA MZCR NT13549-4/2012 and NT13860-4/2012, and the Deutsche Forschungsgemeinschaft (SFB960 to M.K.).
Publisher Copyright:
© 2015. Oncotarget.
PY - 2016
Y1 - 2016
N2 - We determined expression of 83 long non-coding RNAs (lncRNAs) and identified ZFAS1 to be significantly up-regulated in colorectal cancer (CRC) tissue. In cohort of 119 CRC patients we observed that 111 cases displayed at least two-times higher expression of ZFAS1 in CRC compared to paired normal colorectal tissue (P < 0.0001). By use of CRC cell lines (HCT116+/+, HCT116-/- and DLD-1) we showed, that ZFAS1 silencing decreases proliferation through G1-arrest of cell cycle, and also tumorigenicity of CRC cells. We identified Cyclin-dependent kinase 1 (CDK1) as interacting partner of ZFAS1 by pull-down experiment and RNA immunoprecipitation. Further, we have predicted by bioinformatics approach ZFAS1 to sponge miR-590-3p, which was proved to target CDK1. Levels of CDK1 were not affected by ZFAS1 silencing, but cyclin B1 was decreased in both cell lines. We observed significant increase in p53 levels and PARP cleavage in CRC cell lines after ZFAS1 silencing indicating increase in apoptosis. Our data suggest that ZFAS1 may function as oncogene in CRC by two main actions: (i) via destabilization of p53 and through (ii) interaction with CDK1/cyclin B1 complex leading to cell cycle progression and inhibition of apoptosis. However, molecular mechanisms behind these interactions have to be further clarified.
AB - We determined expression of 83 long non-coding RNAs (lncRNAs) and identified ZFAS1 to be significantly up-regulated in colorectal cancer (CRC) tissue. In cohort of 119 CRC patients we observed that 111 cases displayed at least two-times higher expression of ZFAS1 in CRC compared to paired normal colorectal tissue (P < 0.0001). By use of CRC cell lines (HCT116+/+, HCT116-/- and DLD-1) we showed, that ZFAS1 silencing decreases proliferation through G1-arrest of cell cycle, and also tumorigenicity of CRC cells. We identified Cyclin-dependent kinase 1 (CDK1) as interacting partner of ZFAS1 by pull-down experiment and RNA immunoprecipitation. Further, we have predicted by bioinformatics approach ZFAS1 to sponge miR-590-3p, which was proved to target CDK1. Levels of CDK1 were not affected by ZFAS1 silencing, but cyclin B1 was decreased in both cell lines. We observed significant increase in p53 levels and PARP cleavage in CRC cell lines after ZFAS1 silencing indicating increase in apoptosis. Our data suggest that ZFAS1 may function as oncogene in CRC by two main actions: (i) via destabilization of p53 and through (ii) interaction with CDK1/cyclin B1 complex leading to cell cycle progression and inhibition of apoptosis. However, molecular mechanisms behind these interactions have to be further clarified.
UR - http://www.scopus.com/inward/record.url?scp=85021389407&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85021389407&partnerID=8YFLogxK
U2 - 10.18632/ONCOTARGET.5807
DO - 10.18632/ONCOTARGET.5807
M3 - Article
C2 - 26506418
AN - SCOPUS:85021389407
SN - 1949-2553
VL - 7
SP - 622
EP - 637
JO - Oncotarget
JF - Oncotarget
IS - 1
ER -